Literature DB >> 12576552

Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination.

Rosetta Pedotti1, Jason J DeVoss, Sawsan Youssef, Dennis Mitchell, Jochen Wedemeyer, Rami Madanat, Hideki Garren, Paulo Fontoura, Mindy Tsai, Stephen J Galli, Raymond A Sobel, Lawrence Steinman.   

Abstract

Analysis of mRNA from multiple sclerosis lesions revealed increased amounts of transcripts for several genes encoding molecules traditionally associated with allergic responses, including prostaglandin D synthase, histamine receptor type 1 (H1R), platelet activating factor receptor, Ig Fc epsilon receptor 1 (Fc epsilon RI), and tryptase. We now demonstrate that, in the animal model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE), mediated by T helper 1 (Th1) T cells, histamine receptor 1 and 2 (H1R and H2R) are present on inflammatory cells in brain lesions. Th1 cells reactive to myelin proteolipid protein expressed more H1R and less H2R than Th2 cells. Pyrilamine, an H1R antagonist, blocked EAE, and the platelet activating factor receptor antagonist CV6209 reduced the severity of EAE. EAE severity was also decreased in mice with disruption of the genes encoding Ig Fc gamma RIII or both Fc gamma RIII and Fc epsilon RI. Prostaglandin D synthase and tryptase transcripts were elevated in EAE brain. Taken together, these data reveal extensive involvement of elements of the immune response associated with allergy in autoimmune demyelination. The pathogenesis of demyelination must now be viewed as encompassing elements of both Th1 responses and "allergic" responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576552      PMCID: PMC149925          DOI: 10.1073/pnas.252777399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  The role of mast cells in the elicitation of experimental allergic encephalomyelitis.

Authors:  G N Dietsch; D J Hinrichs
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

2.  Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains.

Authors:  R Toms; H L Weiner; D Johnson
Journal:  J Neuroimmunol       Date:  1990-12       Impact factor: 3.478

3.  Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.

Authors:  W L Hazenbos; J E Gessner; F M Hofhuis; H Kuipers; D Meyer; I A Heijnen; R E Schmidt; M Sandor; P J Capel; M Daëron; J G van de Winkel; J S Verbeek
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

4.  Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets.

Authors:  K Tanaka; K Ogawa; K Sugamura; M Nakamura; S Takano; K Nagata
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.

Authors:  J M Spergel; E Mizoguchi; J P Brewer; T R Martin; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

6.  Lack of histamine synthesis and down-regulation of H1 and H2 receptor mRNA levels by dexamethasone in cerebral endothelial cells.

Authors:  K Karlstedt; T Sallmén; K S Eriksson; M Lintunen; P O Couraud; F Joó; P Panula
Journal:  J Cereb Blood Flow Metab       Date:  1999-03       Impact factor: 6.200

7.  Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis.

Authors:  R P Gladue; L A Carroll; A J Milici; D N Scampoli; H A Stukenbrok; E R Pettipher; E D Salter; L Contillo; H J Showell
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

8.  CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.

Authors:  Z Terashita; Y Imura; M Takatani; S Tsushima; K Nishikawa
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

9.  Development of acute autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease.

Authors:  D S Linthicum
Journal:  Immunobiology       Date:  1982-08       Impact factor: 3.144

10.  Identification of Bphs, an autoimmune disease locus, as histamine receptor H1.

Authors:  Runlin Z Ma; Jianfeng Gao; Nathan D Meeker; Parley D Fillmore; Kenneth S K Tung; Takeshi Watanabe; James F Zachary; Halina Offner; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

View more
  39 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

2.  Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.

Authors:  Roxana del Rio; Rajkumar Noubade; Naresha Saligrama; Emma H Wall; Dimitry N Krementsov; Matthew E Poynter; James F Zachary; Robin L Thurmond; Cory Teuscher
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

3.  Immune complexes as therapy for autoimmunity.

Authors:  Raphael Clynes
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

4.  Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  C Ballerini; A Aldinucci; I Luccarini; A Galante; C Manuelli; P Blandina; M Katebe; P L Chazot; E Masini; M B Passani
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

5.  Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis.

Authors:  Gláucia C Furtado; Maria Cecilia G Marcondes; Jo-Ann Latkowski; Julia Tsai; Allen Wensky; Juan J Lafaille
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Gαq takes centre stage in multiple sclerosis pathogenesis.

Authors:  Eric J Downer
Journal:  Cell Mol Immunol       Date:  2017-02-20       Impact factor: 11.530

Review 7.  Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases.

Authors:  Yulong Liu; Lisa B E Shields; Zhongwen Gao; Yuanyi Wang; Yi Ping Zhang; Tianci Chu; Qingsan Zhu; Christopher B Shields; Jun Cai
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

Review 8.  Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis.

Authors:  Kenneth S Rosenthal; Katalin Mikecz; Harold L Steiner; Tibor T Glant; Alison Finnegan; Roy E Carambula; Daniel H Zimmerman
Journal:  Expert Rev Vaccines       Date:  2015-03-18       Impact factor: 5.217

9.  Tryptase is a candidate autoantigen in rheumatoid arthritis.

Authors:  Yanyan Guo; Qiao Wu; Bing Ni; Zhirong Mou; Qiong Jiang; Yi Cao; Hui Dong; Yuzhang Wu
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

10.  Luteolin as a therapeutic option for multiple sclerosis.

Authors:  Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.